Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided TAP block with ropivacaine after elective caesarean section
ACTRN12608000540314Phase 4Completed
- Sponsor
- Mater Misericordiae Health Services Brisbane
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute pain comparing Ultrasound-guided TAP block with ropivacaine with Ultrasound-guided TAP block with saline placebo (2 arms). Primary endpoint: Morphine dose from patient controlled analgesia. Started Sep 2008; status: completed.
02
Drugs
ropivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on ACTRN12608000540314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000540314.